Synthetic CRISPR Spacer Tags for Bacterial Labeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current CRISPR-Cas systems for bacterial immunity are not suitable for labeling and detecting specific bacterial cells without interfering with the cell's natural functions, as they are designed for sequence-specific targeting and interference, which can lead to self-targeting and erroneous behavior within the cellular machinery.

Innovation Solution

Development of synthetic CRISPR spacer polynucleotides and arrays that are non-functional, non-transcribable, and non-targeting, allowing them to be introduced into bacterial CRISPR arrays without triggering the immune response, enabling labeling and detection of specific bacteria by encoding a spacer tag that spells a text when translated, minimizing self-targeting risks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If CRISPR-Cas systems are used for bacterial immunity, then sequence-specific targeting capability is improved, but self-targeting and erroneous behavior occur

Engineering Contradiction:
Improvesequence-specific targeting capabilityVSAvoidself-targeting and erroneous behavior
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The invention extracts only the spacer component from the functional CRISPR-Cas system, creating a non-functional spacer polynucleotide that can be integrated into bacterial CRISPR arrays without the associated harmful targeting and interference activities. This allows the spacer to serve as a safe label without triggering self-targeting or erroneous cellular behavior.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The non-functional spacer polynucleotide acts as an intermediary element that provides the labeling function without mediating the harmful targeting and interference activities of the complete CRISPR-Cas system. It serves as a safe bridge between the desire for specific bacterial identification and the need to avoid cellular disruption.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If functional CRISPR spacers are integrated into bacterial CRISPR arrays, then adaptive immunity is improved, but cellular disruption occurs

Engineering Contradiction:
Improveadaptive immunityVSAvoidcellular disruption
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention removes the functional components (cas genes, promoter regions, and other elements necessary for transcription and interference) from the CRISPR system, leaving only a non-functional spacer polynucleotide. This extracted spacer can be safely integrated into bacterial CRISPR arrays to provide labeling without disrupting cellular functions.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The non-functional spacer polynucleotide serves as a disposable labeling element that can be integrated into the CRISPR array without requiring the complex, energy-intensive, and potentially harmful functional CRISPR-Cas machinery. It provides the necessary identification function without the costly and disruptive biological activity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Adaptability or versatility

If synthetic CRISPR spacer polynucleotides are introduced for labeling, then bacterial identification capability is improved, but system complexity increases

Engineering Contradiction:
Improvebacterial identification capabilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention applies local quality by creating a specifically designed non-functional spacer polynucleotide with unique sequence characteristics (such as encoded text when translated) that provides identification capability at a localized level within the CRISPR array, without requiring complex system-wide changes to the bacterial cell.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The non-functional spacer polynucleotide serves as a simple copy or replica of the spacer component found in functional CRISPR systems, but without the complex associated machinery. This copying approach allows bacterial identification through sequence detection while avoiding the complexity of implementing the full functional CRISPR-Cas system.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20240011024A1Crispr spacer tags for labeling and/or identifying bacteria, and methods of using the same
Publication Date: 2024.01.11 NORTH CAROLINA STATE UNIV
  • US20240011024A1 patent drawing
  • US20240011024A1 patent drawing
  • US20240011024A1 patent drawing

AI summary

This invention relates to synthetic CRISPR spacer polynucleotides and compositions comprising the same such as synthetic spacer-repeat sequences and synthetic CRISPR arrays, wherein the synthetic CRISPR spacer polynucleotides, when translated according to amino acid single-letter code convention, spell a text. Further provided in this invention are methods of using the same for labeling and/or detecting bacteria of interest.